/Investor DB

Sofinnova Partners — 2018 Investments

4 investments dated 2018 · listed companies and verified rows first · show all

Shockwave Medicalshockwavemedical.comin𝕏Dec 2018

Shockwave Medical develops intravascular lithotripsy (IVL) catheter systems used to treat calcified cardiovascular disease, marketed to interventional cardiologists and vascular specialists.

HardwareHealthtechMedical DevicesFremont, US

Daniel Hawkins(Executive Officer, Director)inTodd J. Brinton(Director)inIsaac(President)

BoardJay Watkins(Director)inFrederic H. Moll(Director)

Board seatAntoine Papiernik· per SEC Form D

Co-investorsSonder CapitalVenrockSectoral Asset Management

Rezeranodthera.comin𝕏Series A · Jun 2018 · $40M

NodThera develops clinical-stage small-molecule therapies targeting inflammation for cardiometabolic and neuroinflammatory diseases, including cardiovascular disease, metabolic dysfunction, and neuroinflammation.

BiotechHealthtech

Geoff McDonough(Executive Team / Board)inChris Guiffre(Executive Team)inAlan P. Watt(Executive Team)inJyothis George(Chief Medical Officer)inNick Clarke(Executive Team)in

Co-investors5AM VenturesEpidarex CapitalF-Prime CapitalSanofi Ventures

Velosbiovelosbio.comin𝕏Series A · Oct 2018 · $58M

A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.

BiotechSan Diego, US

David Johnson(Executive Officer, Director)Cam Gallagher(Director)Scott L. Glenn(Director)in

Co-investorsChiesi VenturesDecheng CapitalPappas CapitalSofinnova VenturesVedanta CapitalViking Global+4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Corvidia Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.